Evidence Hub

Quincke’s edema associated with moxifloxacin therapy in communityacquired pneumonia: a case report

V. D. Sorokhan, R. V. Sorokhan

Clinical and experimental pathology, 2026

Abstract

Background: Angioedema, also known as Quincke’s edema, is an acute hypersensitivity reaction characterized by sudden swelling of the skin, subcutaneous tissues, and/or mucous membranes. Drug-induced angioedema is uncommon but potentially life-threatening.

Case Presentation: We report the case of a 55-year-old man with community-acquired pneumonia who developed angioedema during moxifloxacin therapy. The patient initially presented with fever, productive cough, left-sided chest pain, and dyspnea. His medical history was significant for arterial hypertension, treated with lisinopril 5 mg orally once daily. Laboratory investigations revealed elevated liver enzymes, increased creatine kinase levels, and mild renal impairment. On the seventh day of hospitalization, the patient developed acute angioedema, which was successfully treated with intravenous dexamethasone, heparin, and furosemide.

Conclusion: Clinicians should remain vigilant for angioedema in patients receiving fluoroquinolones, particularly when concomitant angiotensin-converting enzyme (ACE) inhibitors are used. Early recognition and prompt management are essential to prevent serious complications.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free